Literature DB >> 2504610

The effect of circulating antigen on radioimmunodetection and monoclonal antibody localisation: studies in a normal rat model.

D R McKay1, G J Bautovich, M R Wilson, K Z Walker.   

Abstract

The effect of circulating antigen (human kappa light chains (LC] on radioimmunoscintigraphy was examined in a normal rat model. Rats were implanted subcutaneously with kappa (test) and lambda (control) LC coupled to sepharose beads (500 micrograms LC/ml swollen gel). When 131I-labelled monoclonal antibody, K-1-21 was injected, clear images of specific antibody localisation to the kappa implant were seen 6 days later. The kappa implant: blood ratio (K:B) was 7.69 +/- 0.45, which represented an implant uptake of 2.52 +/- 0.20 percent injected dose per gram (%ID/g). When 131I-K-1-21 was preincubated with 125I-kappa LC at ratios of up to 1:10 antibody: antigen, (w/w) before injection; or if antigen was given daily by bolus injection or continuously infused via an osmotic pump, very clear specific images of antibody localisation to the kappa implant were still obtained. There was, however, a decline in the absolute uptake of label by the kappa implant. The greatest change was observed following continuous antigen infusion, when kappa implant uptake fell to 1.26 +/- 0.1 %ID/g. Nevertheless, the K:B ratio was still maintained at 6.8 +/- 0.2, due to increased clearance of antibody from the blood. Thus, in this case, where antigen and antibody might be expected to form small, soluble immune complexes, there was no major deleterious effect on radioimmunoscintigraphy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2504610     DOI: 10.1007/bf00435472

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  21 in total

1.  Conformation dependence of a monoclonal antibody defined epitope on free human kappa chains.

Authors:  R L Raison; H A Boux
Journal:  Mol Immunol       Date:  1985-12       Impact factor: 4.407

Review 2.  UCLA conference. Circulating immune complexes: their immunochemistry, detection, and importance.

Authors: 
Journal:  Ann Intern Med       Date:  1979-09       Impact factor: 25.391

3.  A new microsphere-based immunofluorescence assay using flow cytometry.

Authors:  M R Wilson; J S Wotherspoon
Journal:  J Immunol Methods       Date:  1988-03-16       Impact factor: 2.303

4.  Protein iodination using Iodogen.

Authors:  W T Millar; J F Smith
Journal:  Int J Appl Radiat Isot       Date:  1983-03

5.  Radioimmunodetection of cancer with radioactive antibodies to carcinoembryonic antigen.

Authors:  D M Goldenberg; E E Kim; F H DeLand; S Bennett; F J Primus
Journal:  Cancer Res       Date:  1980-08       Impact factor: 12.701

6.  Quantitation of free kappa light chains in serum and urine using a monoclonal antibody based inhibition enzyme-linked immunoassay.

Authors:  S M Axiak; L Krishnamoorthy; J Guinan; R L Raison
Journal:  J Immunol Methods       Date:  1987-05-04       Impact factor: 2.303

Review 7.  Tumor markers as target substances in the radioimmunologic detection of malignancies.

Authors:  S von Kleist
Journal:  Nuklearmedizin       Date:  1986-08       Impact factor: 1.379

8.  The role of the kidney in the catabolism of Bence Jones proteins and immunoglobulin fragments.

Authors:  R D Wochner; W Strober; T A Waldmann
Journal:  J Exp Med       Date:  1967-08-01       Impact factor: 14.307

9.  Circulating immune complexes in cancer patients receiving goat radiolocalizing antibodies to carcinoembryonic antigen.

Authors:  F J Primus; S J Bennett; E E Kim; F H DeLand; M C Zahn; D M Goldenberg
Journal:  Cancer Res       Date:  1980-03       Impact factor: 12.701

10.  Limiting factors in the localization of tumours with radiolabelled antibodies.

Authors:  A R Bradwell; D S Fairweather; P W Dykes; A Keeling; A Vaughan; J Taylor
Journal:  Immunol Today       Date:  1985-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.